pubmed-article:15642670 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15642670 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
pubmed-article:15642670 | lifeskim:mentions | umls-concept:C0012854 | lld:lifeskim |
pubmed-article:15642670 | lifeskim:mentions | umls-concept:C0243043 | lld:lifeskim |
pubmed-article:15642670 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
pubmed-article:15642670 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15642670 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15642670 | pubmed:dateCreated | 2005-1-11 | lld:pubmed |
pubmed-article:15642670 | pubmed:abstractText | Pathogen-derived molecules are danger signals and are able to activate innate immunity that in turn controls and regulates generation of adaptive immune responses. Mycobacterium tuberculosis heat shock protein 70 (myc HSP70) has been shown to exert a potent adjuvant effect in vaccination against both infectious agents and solid tumors. Here we explore the use of myc HSP70, as an adjuvant, in DNA vaccination against lymphoma. | lld:pubmed |
pubmed-article:15642670 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:language | eng | lld:pubmed |
pubmed-article:15642670 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15642670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15642670 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15642670 | pubmed:month | Jan | lld:pubmed |
pubmed-article:15642670 | pubmed:issn | 1592-8721 | lld:pubmed |
pubmed-article:15642670 | pubmed:author | pubmed-author:FaliniBrunang... | lld:pubmed |
pubmed-article:15642670 | pubmed:author | pubmed-author:MarianoAngela... | lld:pubmed |
pubmed-article:15642670 | pubmed:author | pubmed-author:BenedettiRobe... | lld:pubmed |
pubmed-article:15642670 | pubmed:author | pubmed-author:LisoArcangelo... | lld:pubmed |
pubmed-article:15642670 | pubmed:author | pubmed-author:FagioliMartaM | lld:pubmed |
pubmed-article:15642670 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15642670 | pubmed:volume | 90 | lld:pubmed |
pubmed-article:15642670 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15642670 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15642670 | pubmed:pagination | 60-5 | lld:pubmed |
pubmed-article:15642670 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:meshHeading | pubmed-meshheading:15642670... | lld:pubmed |
pubmed-article:15642670 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15642670 | pubmed:articleTitle | Modulatory effects of mycobacterial heat-shock protein 70 in DNA vaccination against lymphoma. | lld:pubmed |
pubmed-article:15642670 | pubmed:affiliation | Sezione di Ematologia, Università di Foggia, viale Pinto, 71100 Foggia, Italy. a.liso@medicina.unifg.it | lld:pubmed |
pubmed-article:15642670 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15642670 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15642670 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15642670 | lld:pubmed |